Reply: Living donor liver transplantation for people with PSC

Affiliations

¹ Univeristy of Colorado, Aurora, Colorado, USA.
² University of Toronto, Toronto, Ontario, Canada.
³ Yale School of Medicine, New Haven, Connecticut USA.
⁴ Saint Antoine Hospital Paris, France.
⁵ Karolinska Institute, Karolinska University Hospital Stockholm, Sweden.
⁶ University of California Davis Health, Sacramento California, USA.
⁷ University of Utah, Salt Lake City, Utah, USA.
⁸ Mayo Clinic College of Medicine and Science Rochester, Minnesota, USA.
⁹ Rutgers University-New Jersey Medical School Newark, New Jersey, USA.
¹⁰ Vagelos College of Physician and Surgeons-Columbia University, New York, New York, USA.
¹¹ University of Arizona, Tuscon, Arizona, USA.
¹² David Geffen School of Medicine at UCLA, Los Angeles, California, USA.

Comment

Lisa M Forman et al. Hepatology. 2023.

. 2023 May 1;77(5):E97-E98.

doi: 10.1097/HEP.0000000000000210. Epub 2023 Jan 3.

¹ Univeristy of Colorado, Aurora, Colorado, USA.
² University of Toronto, Toronto, Ontario, Canada.
³ Yale School of Medicine, New Haven, Connecticut USA.
⁴ Saint Antoine Hospital Paris, France.
⁵ Karolinska Institute, Karolinska University Hospital Stockholm, Sweden.
⁶ University of California Davis Health, Sacramento California, USA.
⁷ University of Utah, Salt Lake City, Utah, USA.
⁸ Mayo Clinic College of Medicine and Science Rochester, Minnesota, USA.
⁹ Rutgers University-New Jersey Medical School Newark, New Jersey, USA.
¹⁰ Vagelos College of Physician and Surgeons-Columbia University, New York, New York, USA.
¹¹ University of Arizona, Tuscon, Arizona, USA.
¹² David Geffen School of Medicine at UCLA, Los Angeles, California, USA.

No abstract available

Comment on

AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma.
Bowlus CL, Arrivé L, Bergquist A, Deneau M, Forman L, Ilyas SI, Lunsford KE, Martinez M, Sapisochin G, Shroff R, Tabibian JH, Assis DN. Bowlus CL, et al. Hepatology. 2023 Feb 1;77(2):659-702. doi: 10.1002/hep.32771. Epub 2022 Oct 20. Hepatology. 2023. PMID: 36083140 No abstract available.
Letter to the Editor: Living donor liver transplantation for people with PSC.
Heinemann M, Adam R, Karam V, Schramm C. Heinemann M, et al. Hepatology. 2023 May 1;77(5):E95-E96. doi: 10.1097/HEP.0000000000000208. Epub 2023 Jan 3. Hepatology. 2023. PMID: 36735268 No abstract available.

1. Bowlus CL, Arrive L, Bergquist A, Deneau M, Forman L, Ilyas SI, et al. AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma. Hepatology. 2022. doi:10.1002/hep.32771. - DOI
1. Heinemann M, Liwinski T, Adam R, Berenguer M, Mirza D, Malek-Hosseini SA, et al. Long-term outcome after living donor liver transplantation compared to donation after brain death in autoimmune liver diseases: experience from the European Liver Transplant Registry. Am J Transplant. 2022;22:626–633.
1. Goldberg DS, French B, Abt PL, Olthoff K, Shaked A. Superior survival using living donors and donor-recipient matching using a novel living donor risk index. Hepatology. 2014;60:1717–1726.
1. Gordon FD, Goldberg DS, Goodrich NP, Lok AS, Verna EC, Selzner N, et al. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: comparison of risk factors between living and deceased donor recipients. Liver Transpl. 2016;22:1214–1222.
1. Jackson WE, Malamon JS, Kaplan B, Saben JL, Schold JD, Pomposelli JJ, et al. Survival benefit of living-donor liver transplant. JAMA Surg. 2022;157:926–932.